查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654271

止血與組織密封劑市場規模、佔有率、趨勢分析報告：按產品、材料、應用、最終用途、地區和細分市場、預測，2025-2030 年

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product, By Material, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10個工作天內

價格

止血和組織密封劑市場的成長和趨勢

根據 Grand View Research, Inc. 的一份新報告，全球止血和組織密封劑市場預計到 2030 年將達到 144.8 億美元。

預計 2025 年至 2030 年間，市場複合年成長率將達到 9.0%。這種成長歸因於人們對微創手術的日益偏好，因為這種手術創傷較小，且需要的恢復時間較短。此外，醫療技術的進步和需要手術的慢性病發病率的上升也促進了這一成長。此外，止血和組織密封產品的技術創新也在推動市場的發展。這些產品的開發是為了滿足各個醫療專業領域的需求，並在各種醫療保健環境中提供有效、高效的手術解決方案。

在預計預測期內，微創技術的快速成長和對更快患者康復的需求將推動市場成長。根據美國美國1.5 億人患有至少一種需要手術治療、有時甚至導致死亡的慢性疾病。預計手術數量的增加最終將推動市場成長。

根據美國疾病管制與預防中心（CDC）的估計，超過 48% 的美國人口患有慢性疾病，這是市場成長的主要驅動力之一。此外，由於手術數量的增加、老年人口的增加和技術的進步，預計止血和組織密封劑市場對產品的需求將增加。一些市場參與企業專注於產品發布、併購和產品核可，以維持其市場地位。例如，2023年11月，強生公司醫療技術部門Ethicon推出止血封貼片Ethizia，並獲得歐洲上市核准，成為其歐洲醫療產品的重要補充。

止血和組織密封劑市場報告重點

  • 2024年，局部止血劑領域佔據最大的市場佔有率。這是因為它擴大與傳統治療方法結合使用，並且具有成本效益、止血劑吸收快速簡便、組織反應性最小和非抗原性等特徵。
  • 2024 年，北美地區佔據了最大的市場佔有率，這得益於該地區完善的醫療保健基礎設施以及心血管疾病、糖尿病和癌症患病率的不斷上升。
  • 市場參與企業正在採取多項策略舉措來擴大其產品覆蓋範圍並提高不同地區的可用性。
  • 主要市場參與企業包括百特、強生、貝朗、史密斯和侄子以及碧迪公司。
  • 材料科學和生物工程的發展正在推動具有更好性能特徵的新型和改良黏合劑和密封劑的開發。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章止血與組織密封劑市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 止血與組織密封劑市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章止血與組織密封劑市場：產品、估計與趨勢分析

  • 細分儀表板
  • 止血劑和組織密封劑市場：2023 年和 2030 年產品變化分析和市場佔有率
  • 局部止血劑
  • 合成止血劑

第 5 章止血劑和組織密封劑市場：按材料分類的估計和趨勢分析

  • 細分儀表板
  • 止血與組織密封劑市場：材料變化分析與市場佔有率，2023 年與 2030 年
  • 明膠基局部止血劑
  • 膠原蛋白局部外用止血劑
  • 基於ORC的局部止血劑
  • 多醣類局部止血劑

第 6 章止血與組織密封劑市場：按應用分類的估計和趨勢分析

  • 細分儀表板
  • 止血和組織密封劑市場：應用趨勢分析和市場佔有率，2023 年和 2030 年
  • 一般外科
  • 神經外科
  • 血管外科
  • 心血管外科
  • 其他

7. 止血與組織密封劑市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 止血和組織密封劑市場：最終用途變化分析和市場佔有率，2024 年和 2030 年
  • 醫院
  • 門診手術中心
  • 其他

8. 止血和組織密封劑市場：區域、估計和趨勢分析

  • 區域展望
  • 止血劑和組織密封劑市場：區域差異分析和市場佔有率，2024 年和 2030 年
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Johnson & Johnson
    • CryoLife Inc
    • Advance Medical Solution（AMS）Group Plc
    • Cohera Medical Inc
    • Integra Life Sciences Corporation
    • Pfizer
    • BD
    • Cohesion Technologies Inc
    • HyperBranch Medical Technology
    • Biomet Inc
    • Medtronic
    • B Braun Medical Inc
    • Smith &Nephew
Product Code: 978-1-68038-597-7

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is anticipated to reach USD 14.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.0% from 2025 to 2030. This growth can be attributed to the increasing preference towards minimally invasive surgical procedures, which are less invasive and require less recovery time. Additionally, advancements in healthcare technology and the rising prevalence of chronic diseases that require surgery are contributing to this growth. The market is also benefiting from ongoing innovation in hemostatic and tissue sealing products, which are being developed to meet the needs of a wide range of medical specialties and to provide effective and efficient surgical solutions in various healthcare settings.

The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times. Such a rise in the number of surgeries is eventually anticipated to foster market growth.

The Centers for Disease Control and Prevention (CDC) estimates that over 48% of the entire American population is expected to suffer from chronic conditions, which is one of the key drivers of this growth. The hemostasis & tissue sealing agents market is also expected to witness an increase in product demand supported by rising surgery volumes, growth in the geriatric population, and technological advancements. Several market participants are focusing on product launches, merger & acquisitions & product approval to sustain their market position. For instance, In November 2023, Johnson & Johnson's MedTech division, Ethicon, introduced Ethizia, a hemostatic sealing patch, obtaining European approval for its launch, marking a significant addition to their medical offerings in Europe.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

  • In 2024, the topical hemostat segment accounted for the largest market share due to its rising use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
  • The North American region held the largest share of the market in 2024 due to well-established healthcare infrastructure, and the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.
  • Some of the major market players are Baxter, Johnson & Johnson, B. Braun, Smith & Nephew, Becton, Dickinson, and Company
  • Advancements in material science and bioengineering have led to the development of new and improved adhesives and sealants with better performance characteristics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Rising preference towards minimally invasive surgical procedures
      • 3.2.1.3. Growing geriatric population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product recall & failure
  • 3.3. Hemostasis & Tissue Sealing Agents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hemostasis & Tissue Sealing Agents Market: Product Movement Analysis & Market Share, 2023 & 2030
  • 4.3. Topical Hemostats
    • 4.3.1. Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Active
        • 4.3.1.1.1. Active market estimates and forecast 2018 to 2030 (USD Million)
      • 4.3.1.2. Mechanical
        • 4.3.1.2.1. Mechanical market estimates and forecast 2018 to 2030 (USD Million)
      • 4.3.1.3. Flowable
        • 4.3.1.3.1. Flowable market estimates and forecast 2018 to 2030 (USD Million)
      • 4.3.1.4. Adhesive & Tissue Sealant
        • 4.3.1.4.1. Adhesive & Tissue Sealant market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4. Synthetic Hemostats
    • 4.4.1. Synthetic Hemostasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Natural
        • 4.4.1.1.1. Natural market estimates and forecast 2018 to 2030 (USD Million)
      • 4.4.1.2. Adhesion Barrier
        • 4.4.1.2.1. Adhesion Barrier market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hemostasis & Tissue Sealing Agents Market: Material Movement Analysis & Market Share, 2023 & 2030
  • 5.3. Gelatin-based Topical Hemostats
    • 5.3.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Collagen-based Topical Hemostats
    • 5.4.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. ORC-based Topical Hemostats
    • 5.5.1. ORC-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Polysaccharide-based Topical Hemostats
    • 5.6.1. Polysaccharide-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis & Tissue Sealing Agents Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hemostasis & Tissue Sealing Agents Market: Application Movement Analysis & Market Share, 2023 & 2030
  • 6.3. General Surgery
    • 6.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Neurosurgery
    • 6.4.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Vascular Surgery
    • 6.5.1. Vascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiovascular Surgery
    • 6.6.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis & Tissue Sealing Agents Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Hemostasis & Tissue Sealing Agents Market: End-use Movement Analysis & Market Share, 2024 & 2030
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Hemostasis & Tissue Sealing Agents Market: Regional Movement Analysis & Market Share, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Denmark Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Sweden Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. Japan Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. China Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Mexico Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. Argentina Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Johnson & Johnson
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. CryoLife Inc
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Advance Medical Solution (AMS) Group Plc
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Cohera Medical Inc
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Integra Life Sciences Corporation
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Pfizer
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. BD
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Cohesion Technologies Inc
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. HyperBranch Medical Technology
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Biomet Inc
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Medtronic
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. B Braun Medical Inc
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Smith & Nephew
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 5 Global hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America hemostasis and tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 10 North America hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 14 U.S. hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 18 Canada hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 23 Europe hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 UK hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 27 UK hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Germany hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 31 Germany hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 34 France hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 35 France hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 36 France hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 39 Italy hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 43 Spain hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Norway hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 46 Norway hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 47 Norway hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 48 Norway hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 51 Sweden hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Denmark hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 54 Denmark hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 55 Denmark hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 56 Denmark hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Japan hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 63 Japan hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 64 Japan hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 China hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 67 China hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 68 China hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 69 China hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 71 India hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 72 India hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 73 India hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Australia hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 75 Australia hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 76 Australia hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 South Korea hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Korea hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 80 South Korea hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 84 Thailand hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 89 Latin America hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 93 Brazil hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 97 Mexico hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 101 Argentina hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa hemostasis and tissue sealing agents market, by country, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 110 South Africa hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 118 UAE hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE hemostats market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait hemostats market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait hemostats market, by material, 2018 - 2030 (USD Million)
  • Table 122 Kuwait hemostats market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait hemostats market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Hemostats market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Hemostasis and tissue sealing agents market, product outlook key takeaways (USD Million)
  • Fig. 12 Hemostasis and tissue sealing agents market: product movement analysis 2024 & 2030 (USD Million)
  • Fig. 13 Topical hemostat market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Adhesive & tissue sealant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Hemostasis and tissue sealing agents market, material outlook key takeaways (USD Million)
  • Fig. 16 Hemostasis and tissue sealing agents market: material movement analysis 2024 & 2030 (USD Million)
  • Fig. 17 Gelatin-based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Collagen based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 ORC- based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Polysaccharide-based topical hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Hemostasis and tissue sealing agents market, application outlook key takeaways (USD Million)
  • Fig. 22 Hemostasis and tissue sealing agents market: application movement analysis 2024 & 2030 (USD Million)
  • Fig. 23 General surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Neurosurgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cardiovascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Hemostasis and tissue sealing agents market, end-use outlook key takeaways (USD Million)
  • Fig. 29 Hemostasis and tissue sealing agents market: end-use movement analysis 2024 & 2030 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Hemostasis and tissue sealing agents market : Regional key takeaways (USD Million)
  • Fig. 34 Hemostasis and tissue sealing agents market: Regional outlook, 2024 & 2030 (USD Million)
  • Fig. 35 North America hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait hemostasis and tissue sealing agents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 List of key emerging company's/technology disruptors/innovators